Gaetano Ciancio

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. ncbi Development of a surgical safety checklist for the performance of radical nephrectomy and tumor thrombectomy
    Shivam Joshi
    Miami Transplant Institute, Miami, FL, USA
    Patient Saf Surg 6:27. 2012
  2. ncbi Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation
    Gaetano Ciancio
    Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
    Transplantation 92:1348-57. 2011
  3. ncbi A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring
    Gaetano Ciancio
    Dept of Surgery, The Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation, University of Miami Leonard M Miller School of Medicine, and the Miami Veterans Affairs Medical Center, Miami, Florida 33101, USA
    Transplantation 80:457-65. 2005
  4. ncbi Immunosuppressive treatment options in renal transplantation
    G Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Minerva Urol Nefrol 57:141-9. 2005
  5. ncbi Donor bone marrow infusion in deceased and living donor renal transplantation
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, P O Box 012440, Miami, FL 33101, USA
    Yonsei Med J 45:998-1003. 2004
  6. ncbi The use of Campath-1H as induction therapy in renal transplantation: preliminary results
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Transplantation 78:426-33. 2004
  7. ncbi Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Clin Transplant 18:402-6. 2004
  8. ncbi A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Transplantation 77:252-8. 2004
  9. ncbi A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101, USA
    Transplantation 77:244-51. 2004
  10. ncbi The use of daclizumab as induction therapy in combination with tacrolimus and mycophenolate mofetil in recipients with previous transplants
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, School of Medicine, University of Miami, Miami, FL 33101, USA
    Clin Transplant 17:428-32. 2003

Detail Information

Publications108 found, 100 shown here

  1. ncbi Development of a surgical safety checklist for the performance of radical nephrectomy and tumor thrombectomy
    Shivam Joshi
    Miami Transplant Institute, Miami, FL, USA
    Patient Saf Surg 6:27. 2012
    ..abstract:..
  2. ncbi Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation
    Gaetano Ciancio
    Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
    Transplantation 92:1348-57. 2011
    ..Given our previous experience using dual-induction therapy with antithymocyte globulin (ATG)/daclizumab (Dac) (each with fewer doses than if used alone), we chose to compare two distinct dual-induction strategies...
  3. ncbi A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring
    Gaetano Ciancio
    Dept of Surgery, The Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation, University of Miami Leonard M Miller School of Medicine, and the Miami Veterans Affairs Medical Center, Miami, Florida 33101, USA
    Transplantation 80:457-65. 2005
    ..New trends in immunosuppression in clinical transplantation include the use of antibody induction agents in protocols that emphasize reduction or avoidance of steroids and calcineurin inhibitors...
  4. ncbi Immunosuppressive treatment options in renal transplantation
    G Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Minerva Urol Nefrol 57:141-9. 2005
    ..Recent protocols and clinical experience with modern immunosuppression strategies, as well as the efficacy and safety of various combination protocols, will be reviewed...
  5. ncbi Donor bone marrow infusion in deceased and living donor renal transplantation
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, P O Box 012440, Miami, FL 33101, USA
    Yonsei Med J 45:998-1003. 2004
    ....
  6. ncbi The use of Campath-1H as induction therapy in renal transplantation: preliminary results
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Transplantation 78:426-33. 2004
    ....
  7. ncbi Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Clin Transplant 18:402-6. 2004
    ....
  8. ncbi A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Transplantation 77:252-8. 2004
    ..Adjunctive Siro therapy with a similar dose reduction algorithm for Neoral (Neo) was included for comparison...
  9. ncbi A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101, USA
    Transplantation 77:244-51. 2004
    ....
  10. ncbi The use of daclizumab as induction therapy in combination with tacrolimus and mycophenolate mofetil in recipients with previous transplants
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, School of Medicine, University of Miami, Miami, FL 33101, USA
    Clin Transplant 17:428-32. 2003
    ..Acute rejection rate was 0% for group A, 12.5% for group B, and 0% for group C. Daclizumab induction therapy is effective for patients with previous transplants and does not appear to increase the risk of acute rejection...
  11. ncbi Early ligation of the renal artery using the posterior approach: a basic surgical concept reinforced during resection of large hypervascular renal cell carcinoma with or without inferior vena cava thrombus
    G Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101, USA
    BJU Int 92:488-9. 2003
  12. ncbi The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL, USA
    Am J Transplant 3:1010-6. 2003
    ....
  13. ncbi Resection of the abdominal inferior vena cava for complicated renal cell carcinoma with tumour thrombus
    Gaetano Ciancio
    Department of Surgery Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    BJU Int 96:815-8. 2005
    ....
  14. ncbi Review of major clinical trials with mycophenolate mofetil in renal transplantation
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, Lillian Jean Kaplan Renal Transplant Center, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33101, USA
    Transplantation 80:S191-200. 2005
    ....
  15. ncbi A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis
    Gaetano Ciancio
    The Lillian Jean Kaplan Renal Transplant Center, Department of Surgery, Division of Transplantation, University of Miami Miller School of Medicine, PO Box 012440, Miami, FL 33101, USA
    Transplantation 81:845-52. 2006
    ..We report three-year (interim) effects of combining sirolimus (Siro) vs. mycophenolate mofetil (MMF) as adjunctive therapy with calcineurin inhibitors (CI) in renal transplantation in the three different CI-based regimens...
  16. ncbi Machine perfusion following static cold storage preservation in kidney transplantation: donor-matched pair analysis of the prognostic impact of longer pump time
    Gaetano Ciancio
    The Lillian Jean Kaplan Renal Transplant Center, Leonard M Miller School of Medicine, University of Miami, FL 33101, USA
    Transpl Int 25:34-40. 2012
    ..While offering significantly favorable protection from BPAR, this analysis of donor-matched recipient pairs corroborates longer MP (pump) times having no unfavorable effect on other clinical outcomes...
  17. ncbi Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis
    Gaetano Ciancio
    The Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation, Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33101, USA
    Transplantation 91:1198-205. 2011
    ..This report includes 3 additional years of follow-up with similar endpoints as in the original study...
  18. ncbi Transplantation of en bloc pediatric kidneys with a partial bladder segment in an adult recipient
    Gaetano Ciancio
    The Department of Surgery, University of Miami Leonard M Miller School of Medicine, Miami, FL, USA
    Transpl Int 22:350-3. 2009
    ..It seems that bladder transplantation en bloc with pediatric kidneys is a viable option for augmentation of a small recipient bladder that allows avoidance of very small bilateral ureteroneocystotomies...
  19. ncbi Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up
    Gaetano Ciancio
    The Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation, Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
    Transplantation 86:67-74. 2008
    ..It was of interest to compare enteric-coated mycophenolate sodium (EC-MPS) versus mycophenolate mofetil (MMF) among renal transplant recipients receiving a tacrolimus-based immunosuppressive regimen...
  20. ncbi Campath-1H induction therapy in African American and Hispanic first renal transplant recipients: 3-year actuarial follow-up
    Gaetano Ciancio
    Lillian Jean Kaplan Renal Transplant Center, Division of Transplantation, Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33101, USA
    Transplantation 85:507-16. 2008
    ..In a retrospective study of the first 75 primary renal transplant patients given alemtuzumab induction at our center, 20 were African American (27%), 32 were Hispanic (43%), and 23 were non-African American, non-Hispanic (31%)...
  21. ncbi A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up
    Gaetano Ciancio
    Department of Surgery, The Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation, University of Miami Leonard M Miller School of Medicine, Miami, FL 33101, USA
    Clin Transplant 22:200-10. 2008
    ..A long-term prospective randomized trial evaluating alemtuzumab, a humanized anti-CD52 monoclonal antibody, in a predominantly non-Caucasian population has yet to be reported...
  22. ncbi Alemtuzumab (Campath-1H) in kidney transplantation
    G Ciancio
    Department of Surgery, Division of Transplantation, University of Miami Miller School of Medicine, Miami, FL, USA
    Am J Transplant 8:15-20. 2008
    ..As extrapolation from short-term data is far from secure, long-term, prospective, randomized studies with Alemtuzumab will be necessary to determine the optimal immunosuppressive regimen...
  23. ncbi Induction therapy in renal transplantation : an overview of current developments
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    Drugs 67:2667-80. 2007
    ..The specific agents used for induction therapy to date, and the rationale for their introduction and mechanisms of action are discussed in this review...
  24. ncbi Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida, USA
    Eur Urol 51:988-94; discussion 994-5. 2007
    ..We developed a technique for safe resection of these tumors through a transabdominal approach, without recourse to cardiopulmonary bypass (CPB)...
  25. ncbi Efficacy of alemtuzumab in organ transplantation: current clinical status
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    BioDrugs 20:85-92. 2006
    ....
  26. ncbi Daclizumab as induction therapy in kidney and simultaneous pancreas-kidney transplantation
    G Ciancio
    Division of Transplantation, Department of Surgery, University of Miami School of Medicine, Miami, FL 33101, USA
    Minerva Urol Nefrol 55:43-56. 2003
    ..Data from clinical trials show daclizumab to be well tolerated in solid organ transplantation. It does not increase the incidence of infection, including cytomegalovirus infection...
  27. ncbi Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Highland Professional Building 5th Floor, 1801 NW 5th Avenue, Suite 517, Miami, FL 33136, USA
    Transplant Proc 34:1944-5. 2002
  28. ncbi Renal cell carcinoma invading the hepatic veins
    G Ciancio
    Division of Transplantation, Department of Surgery, University of Miami School of Medicine, P O Box 012440, Miami, FL 33101, USA
    Cancer 92:1836-42. 2001
    ..Complete mobilization of the liver and rotation of the inferior vena cava enhances exposure of the ostium of the hepatic veins. This maneuver allows for the complete removal of tumor from the hepatic veins and decompression of the liver...
  29. ncbi Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA E mail
    Transplantation 74:488-96. 2002
    ..4% in the iliac crest bone marrow compartment now at 6 years). Prompted by this, we embarked on a study of DBMC infusion in living-related donor (LRD) kidney transplant recipients...
  30. ncbi The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas--kidney recipients with previous transplants
    G Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Clin Transplant 15:142-5. 2001
    ..The results indicate the TAC i.v. in combination with oral TAC, MMF, and steroids offer effective induction therapy in patients with previous transplants...
  31. ncbi Allograft pancreatic duct dilatation following bladder drained simultaneous pancreas-kidney transplantation: clinical significance
    G Ciancio
    University of Miami School of Medicine, Department of Surgery, Division of Transplantation, Miami, FL 33101, USA
    JOP 1:4-12. 2000
    ..Radiologic imaging of the allograft pancreatic duct dilatation is an uncommon multifactorial finding that is not well described. The purpose of this investigation is to determine the clinical correlation of this finding...
  32. ncbi Current treatment practice in immunosuppression
    G Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, PO Box 012440, Miami, FL 33101, USA
    Expert Opin Pharmacother 1:1307-30. 2000
    ..Others, affecting different intra- or intercellular messages amplifying immunity, are in the pipeline...
  33. ncbi Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Highland Professional Building, 5th Floor, 1801 NW 9th Avenue, Suite 517, Miami, FL 33136, USA
    Transplant Proc 34:1617-8. 2002
  34. ncbi Partial venous thrombosis of the pancreatic allografts after simultaneous pancreas-kidney transplantation
    G Ciancio
    Department of Surgery, University of Miami School of Medicine, FL 33101, USA
    Clin Transplant 14:464-71. 2000
    ..The i.v. use of TAC appears to be a risk factor for the increased incidence of VT. Currently, using IL-2rmAb as induction, TAC is started orally on postoperative days 3 or 4 and aspirin on postoperative day 2...
  35. ncbi Donor bone marrow infusion in cadaveric renal transplantation
    G Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida, USA
    Transplant Proc 35:871-2. 2003
  36. ncbi Six-year clinical effect of donor bone marrow infusions in renal transplant patients
    G Ciancio
    Department of Surgery, Diabetes Research Institute, University of Miami School of Medicine, Florida 33101, USA
    Transplantation 71:827-35. 2001
    ....
  37. ncbi Randomized trial of immunosuppressive regimens in renal transplantation
    Giselle Guerra
    Department of Medicine, Division of Nephrology, University of Miami Miller School of Medicine, P O Box 012440 R 440, Miami, FL 33101, USA
    J Am Soc Nephrol 22:1758-68. 2011
    ..Taken together, these results suggest that maintenance therapy with tacrolimus/MMF is more favorable than either tacrolimus/sirolimus or cyclosporine/sirolimus...
  38. ncbi Campath-1H does not alter bone marrow cell regulatory function
    Yide Jin
    Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation of the Department of Surgery, at the University of Miami, Leonard M Miller School of Medicine, Miami, FL 33101, USA
    Hum Immunol 66:637-43. 2005
    ..These in vitro studies suggest that C1H does not abrogate BMC immunoregulation and thus may allow its lympho-depleting effect to be synergistic...
  39. ncbi Donor bone marrow transplantation: chimerism and tolerance
    Spiros Delis
    Department of Surgery, Division of Kidney, Kidney/Pancreas Transplant, University of Miami School of Medicine, Miami, FL, USA
    Transpl Immunol 13:105-15. 2004
    ..Major advances have been made in animal models and in pilot clinical trials and the key questions with the future perspectives are presented in this article...
  40. ncbi FoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusion
    Robert E Cirocco
    Department of Surgery, The Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation, University of Miami Leonard M Miller School of Medicine, Miami, FL 33101, USA
    Transplantation 83:1611-9. 2007
    ..We questioned if this was associated with putatively regulatory FoxP3 mRNA and cell phenotypes (CD4+CD25+high percentages and high DC2:DC1 ratios) in DBMC-i vs. noninfused controls...
  41. ncbi Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Transplantation 73:1100-6. 2002
    ....
  42. ncbi Renal carcinoma with supradiaphragmatic tumor thrombus: avoiding sternotomy and cardiopulmonary bypass
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    Ann Thorac Surg 89:505-10. 2010
    ..Clinical outcomes of these patients and techniques are reported...
  43. ncbi Favorable outcomes with machine perfusion and longer pump times in kidney transplantation: a single-center, observational study
    Gaetano Ciancio
    Leonard M Miller School of Medicine, University of Miami, Miami, FL, USA
    Transplantation 90:882-90. 2010
    ..Because a lack of consensus regarding optimal use of MP still exists, we evaluated the overall impact of using MP at our center and the prognostic value of MP (Pump) time...
  44. ncbi Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow
    Yide Jin
    Department of Surgery, University of Miami School of Medicine, Miami, FL 33101, USA
    Hum Immunol 65:93-103. 2004
    ..The observed in vitro deficiency of this function by immature bone marrow cells may therefore contribute to the immune downregulatory capacity seen in the BMC compartment...
  45. ncbi Addition of anti-CD25 to thymoglobulin for induction therapy: delayed return of peripheral blood CD25-positive population
    Junichiro Sageshima
    Division of Kidney and Pancreas Transplantation, Department of Surgery, University of Miami, Miller School of Medicine, 1801 NW 9th Ave, 5th Fl, Miami, FL 33136, USA
    Clin Transplant 25:E132-5. 2011
    ..This strategy may result in reduced allogeneic (donor-specific) T effector cells at the time of solid organ transplantation...
  46. ncbi Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation
    James M Mathew
    Department of Surgery, University of Miami School of Medicine, Florida 33136, USA
    Transplantation 74:846-55. 2002
    ..Therefore, we questioned whether an intrinsic immunoregulatory function of (subpopulations of) DBMC might play a role in this observation...
  47. ncbi En bloc mobilization of the pancreas and spleen to facilitate resection of large tumors, primarily renal and adrenal, in the left upper quadrant of the abdomen: techniques derived from multivisceral transplantation
    Gaetano Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101, USA
    Eur Urol 55:1106-11. 2009
    ..When these lesions are large, safely resecting them often presents a significant technical challenge, with the possibility of resultant morbidity and mortality...
  48. ncbi Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation
    Junichiro Sageshima
    DeWitt Daughtry Family Department of Surgery, University of Miami Leonard M Miller School of Medicine, Miami, Florida 33136, USA
    Transpl Immunol 25:104-11. 2011
    ..Overall, with extensive and persistent lymphocyte suppression by a simple administration of agents, single-dose rATG+C1H induction can be an alternative in renal transplantation...
  49. ncbi A novel approach to detect donor/recipent immune responses between HLA-identical pairs
    Yide Jin
    Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation of the Department of Surgery, University of Miami, Leonard M Miller School of Medicine, Miami, Florida 33101, USA
    Hum Immunol 68:350-61. 2007
    ....
  50. ncbi Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation
    James M Mathew
    Department of Surgery, Division of Transplantation R 440, University of Miami School of Medicine, 1600 N W 10th Ave, Miami, FL 33136, USA
    Transpl Immunol 11:307-21. 2003
    ..These studies all suggested a strong inhibitory property of a number of DBMC sub-populations in vitro and in vivo with the notion that they promote unresponsiveness...
  51. ncbi BK virus nephropathy after simultaneous pancreas-kidney transplantation
    Edip Akpinar
    Division of Transplantation, Departments of Surgery and Pathology, The Lillian Jean Kaplan Renal Transplant Center, Leonard M Miller School of Medicine, University of Miami, Miami, FL, USA
    Clin Transplant 24:801-6. 2010
    ..BK virus nephropathy (BKVN) was reported in up to 7.5% of patients after simultaneous pancreas-kidney transplantation (SPK). Its management by reduction in immunosuppression might pre-dispose to pancreatic graft loss...
  52. ncbi Human donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cells
    Manuel R Carreno
    Departments of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Hum Immunol 64:21-30. 2003
    ..These in vitro findings support the notion that (allogeneic) DBMC infusions can induce a T4 suppressor (regulatory) influence and thereby indirectly affect B-cell function...
  53. ncbi Techniques for avoidance of sternotomy and cardiopulmonary bypass during resection of extensive renal cell carcinoma with vena caval tumor thrombus extension above the diaphragm
    Gaetano Ciancio
    Division of Transplantation, Department of Surgery, University of Miami Miller School of Medicine and Jackson Memorial Hospital, Miami, Florida, USA
    J Card Surg 24:657-60. 2009
    ....
  54. ncbi Effect of kidney transplantation on outcomes among patients with hepatitis C
    David Roth
    Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    J Am Soc Nephrol 22:1152-60. 2011
    ..Nevertheless, the higher incidence of early infection-related deaths after transplant calls for further study to determine the optimal immunosuppressive protocol...
  55. ncbi Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells
    Francesco Vendrame
    Diabetes Research Institute, Leonard Miller School of Medicine, University of Miami, Miami, Florida, USA
    Diabetes 59:947-57. 2010
    ..To investigate if recurrent autoimmunity explained hyperglycemia and C-peptide loss in three immunosuppressed simultaneous pancreas-kidney (SPK) transplant recipients...
  56. ncbi Contemporary open partial nephrectomy is associated with diminished procedure-specific morbidity despite increasing technical challenges: a single institutional experience
    Bruce R Kava
    Department of Urology, Miller School of Medicine, University of Miami, PO Box 016960 M814, Miami, FL 33101, USA
    World J Urol 28:507-12. 2010
    ..To review trends in open partial nephrectomy (OPN) at our center, concentrating on patient selection, technique and perioperative complications...
  57. ncbi Induction of auto-reactive regulatory T cells by stimulation with immature autologous dendritic cells
    Yide Jin
    The Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation of the Department of Surgery, University of Miami, Leonard M Miller School of Medicine, Miami, Florida 33101, USA
    Immunol Invest 36:213-32. 2007
    ..This regulation appeared to require cell-to-cell contact...
  58. ncbi Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation
    Pablo Cure
    Clinical Islet Transplant Program and Cell Transplant Center, Diabetes Research Institute, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    Transplantation 85:801-12. 2008
    ..The beneficial effects of glycemic control on both survival and function of transplanted kidneys in patients with type 1 diabetes mellitus (T1DM) and end-stage renal disease (ESRD) have been recognized...
  59. ncbi Simultaneous pancreas-kidney transplantation in Jehovah's Witness patients
    Jose Figueiro
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Clin Transplant 17:140-3. 2003
    ..Finally, it is critical that the pre-operative evaluation demonstrates sufficient cardiac reserve to allow the JW patient to tolerate a possible temporary anemic state...
  60. ncbi Management of renal cell carcinoma with level III thrombus in the inferior vena cava
    Gaetano Ciancio
    Department of Surgery, Division of Transpalntation, University of Miami School of Medicine, Floria, USA
    J Urol 168:1374-7. 2002
    ....
  61. ncbi Hypercoagulable state associated with kidney-pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy
    George W Burke
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Clin Transplant 18:423-8. 2004
    ..This has led us to perform intra-operative thromboelastograms (TEG's) to evaluate the patient's current coagulation status...
  62. ncbi A novel micro-cell-mediated lympholytic assay for the evaluation of regulatory cells in human alloreactive CTL responses
    James M Mathew
    Division of Transplantation, Department of Surgery, University of Miami School of Medicine, R 440, 1600 N W 10th Ave, FL 33136, USA
    J Immunol Methods 272:67-80. 2003
    ....
  63. ncbi Modified surgical technique for the management of renal cell carcinoma with level I or II tumor thrombus
    Michael A Gorin
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    Urology 79:478-81. 2012
    ..To describe a modified open surgical technique for the resection of renal cell carcinoma with level I or II tumor thrombus...
  64. ncbi Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience
    Gaetano Ciancio
    Department of Urology, Miller School of Medicine, University of Miami, Miami, FL 33101, USA
    Eur Urol 57:667-72. 2010
    ..Renal cell carcinoma (RCC) with a tumor thrombus extension into the inferior vena cava (IVC) demands aggressive surgical management...
  65. ncbi Tumor thrombus involving the inferior vena cava in renal malignancy: is there a difference in clinical presentation and outcome among right and left side tumors?
    Devendar Katkoori
    Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida 33101, USA
    Int Braz J Urol 35:652-6; discussion 656-7. 2009
    ..Due to inherent differences in the venous anatomy of the right and left kidneys, tumor thrombus involvement of IVC may vary. The aim of this study is to compare clinical presentation and outcome of right vs. left RCC with IVC thrombus...
  66. ncbi En bloc mobilization of the inferior vena cava and large hypervascular right renal tumors with or without inferior vena cava thrombus: Posterior ligation of the renal artery
    Gaetano Ciancio
    Department of Surgery (Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida, USA
    Int J Urol 13:1144-6. 2006
    ..In our experience, the use of this posterior approach for renal artery ligation is safe and effective, even with large renal tumors with multiple collaterals and/or lymph nodes making the identification of the renal artery difficult...
  67. ncbi Living donor nephrectomy: University of Miami technique and current results
    Samir P Shirodkar
    Department of Surgery, University of Miami School of Medicine, Miami, Florida 33101, USA
    Arch Esp Urol 63:163-70. 2010
    ..The University of Miami/Jackson Memorial Hospital Transplant Center performs a large number of living-donor nephrectomies, with increasing use of LDN and here we report our cumulative experience...
  68. ncbi Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression
    G Ciancio
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, Florida 33101, USA
    Transplant Proc 35:873-4. 2003
  69. ncbi Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience
    Hans Hubsch
    Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, P.O. Box 016960 (M-714, Miami, FL 33101, USA
    Pediatr Nephrol 20:210-6. 2005
    ..In conclusion, our experience suggests that, with recurrent FSGS, a limited course of PP followed by maintenance therapy with AB and MMF improves symptoms and may preserve allograft function...
  70. ncbi The role of liver transplantation techniques in the surgical management of advanced renal urothelial carcinoma with or without inferior vena cava thrombus
    Wolfgang H Cerwinka
    Department of Urology, Division of Transplantation, University of Miami Miller School of Medicine, Miami, Florida, USA
    Int Braz J Urol 35:19-23. 2009
    ..The purpose of this study was to present the surgical management of large and locally-advanced urothelial tumors arising from the renal pelvis using liver transplantation techniques and to evaluate patient outcome...
  71. ncbi Cold infusion for salvage partial hilar nephrectomy in patient with bilateral wilms tumor
    Anthony R Hogan
    Department of Surgery, Division of Pediatric Surgery, DeWitt Daughtry Family, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Urology 73:1021-3. 2009
    ..The adequate renal function afforded by the procedure avoided the possible need for dialysis and allowed the resection area to be irradiated to prevent tumor recurrence before eventual renal transplantation...
  72. ncbi Combined pancreas and en bloc kidney transplantation using a bladder patch technique from very small pediatric donors
    J Sageshima
    The DeWitt Daughtry Family Department of Surgery, University of Miami Leonard M Miller School of Medicine, Miami, FL, USA
    Am J Transplant 10:2168-72. 2010
    ..These cases illustrate the feasibility of combined pancreas and en bloc kidney transplantation from very small pediatric donors using a bladder patch technique to avoid small ureteral anastomosis...
  73. ncbi Advances in pancreas transplantation
    George W Burke
    Lillian Jean Kaplan Renal Transplantation Center, University of Miami/Jackson Memorial Medical Center, Miami, FL 33136, USA
    Transplantation 77:S62-7. 2004
    ..To further improve therapeutic options for patients with type 1 diabetes or end-stage renal disease, pancreatic islet transplantation and organ and islet xenotransplantation should be further explored...
  74. ncbi Renal cell cancer with invasive atrial tumor thrombus excised off-pump
    Wolfgang H Cerwinka
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA
    Urology 66:1319. 2005
    ..The invasive tumor thrombus was sharply excised off the atrial wall. If serious medical conditions do not permit the use of cardiopulmonary bypass, it is technically feasible to excise a wall-invasive atrial tumor thrombus off-pump...
  75. ncbi Renal cell carcinoma with tumor thrombus extending above diaphragm: avoiding cardiopulmonary bypass
    Gaetano Ciancio
    Division of Transplantation, Department of Surgery, University of Miami School of Medicine, Miami, Florida 33101, USA
    Urology 66:266-70. 2005
    ..1 months, and 5 patients were disease free. CONCLUSIONS: In select cases, renal cell carcinoma extending into the supradiaphragmatic IVC and right atrium can be resected without the use of CPB. We describe our technique...
  76. ncbi Vascular stapling of the inferior vena cava: further refinement of techniques for the excision of extensive renal cell carcinoma with unresectable vena-caval involvement
    Samir P Shirodkar
    Department of Urology, University of Miami School of Medicine, Miami, Florida, USA
    Urology 74:846-50. 2009
    ..Options for tumor excision include thrombectomy with or without cardiopulmonary bypass, replacement of the cava with synthetic or venous graft, or caval excision without replacement...
  77. ncbi Bone marrow-induced tolerance in the era of pancreas and islets transplantation
    Spiros Delis
    Division of Kidney and Kidney/Pancreas Transplant, Department of Surgery, University of Miami School of Medicine, Miami, FL 33101, USA
    Pancreas 32:1-8. 2006
    ..A review of the more important advances in the field and the future prospects combined with our experience to induce tolerance in the clinic and the laboratory is presented in this article...
  78. ncbi Diabetic muscle infarction after simultaneous pancreas-kidney transplant
    Spiros Delis
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33101, USA
    Clin Transplant 16:295-300. 2002
    ..This may be exacerbated by the pro-coagulant effects of the calcineurin-inhibitors and the use of steroids as part of the immunosuppressive regimen...
  79. ncbi Functional and phenotypic properties of peripheral T cells anergized by autologous CD3(+) depleted bone marrow cells
    Yide Jin
    Department of Surgery, University of Miami School of Medicine, Miami, FL 33136, USA
    Hum Immunol 63:567-75. 2002
    ..These in vitro observations may provide a mechanism by which infused donor BMC serve to downregulate T-cell immunity...
  80. ncbi Retrospective assessment of islet cell autoantibodies in pancreas organ donors
    Stavros Diamantopoulos
    Diabetes Research Institute, Leonard Miller School of Medicine, University of Miami, Miami, Florida, USA
    Diabetes Care 31:1741-2. 2008
    ..We investigated whether donor AAb positivity could affect the outcome of pancreas transplantation...
  81. ncbi Right atrial and pulmonary tumor embolism from renal rhabdomyosarcoma
    Lisardo Garcia-Covarrubias
    Division of Cardiothoracic Surgery, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
    J Card Surg 23:778-80. 2008
    ..He was discharged on postoperative day 13. To our knowledge this is the first case of large tumor embolism to the right atrium and pulmonary artery from renal rhabdomyosarcoma reported in the literature...
  82. ncbi Arterial reconstruction with donor iliac vessels during pancreas transplantation: an intraoperative approach to arterial injury or inadequate flow
    Jang Il Moon
    Division of Transplantation, Department of Surgery, University of Miami School of Medicine, Miami, FL, USA
    Clin Transplant 19:286-90. 2005
    ....
  83. ncbi Show me the money--immunosuppression in kidney transplantation
    George W Burke
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Miami, FL 33136, USA
    Lancet 364:481-3. 2004
  84. ncbi Two decades of pediatric kidney transplantation in a multi-ethnic cohort
    Samina Muneeruddin
    Division of Pediatric Nephrology, Department of Pediatrics, Holtz Children s Hospital, Miami, FL 33101, USA
    Pediatr Transplant 14:667-74. 2010
    ..Strategies to improve supportive services and living donations in minority populations need to be developed. Long-term renal allograft survival is achievable if GFR is maintained >60 mL/min/1.73 m(2)...
  85. ncbi Ex vivo repair and renal autotransplantation after penetrating trauma: is there an upper limit of ischemic/traumatic injury beyond which a kidney is unsalvageable?
    Michael Angelis
    Department of Surgery, Division of Transpalntation, Tufts University School of Medicine, Boston, Massachusetts, USA
    J Trauma 54:606-9; discussion 609. 2003
  86. ncbi Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis
    Alessia Fornoni
    Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Sci Transl Med 3:85ra46. 2011
    ..Our study suggests that treatment of high-risk patients with rituximab at time of kidney transplant might prevent recurrent FSGS by modulating podocyte function in an SMPDL-3b-dependent manner...
  87. ncbi Islet cell transplantation: should we use more than one pancreas? Con
    G W Burke
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, PO Box 012440, Miami, FL 33101, USA
    Transplant Proc 34:1925-6. 2002
  88. ncbi Steroid-resistant acute rejection following SPK: importance of maintaining therapeutic dosing in a triple-drug regimen
    George W Burke
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Highland Professional Building 5th Floor, 1801 NW 9th Avenue, Rm. 521, Miami, FL 33136, USA
    Transplant Proc 34:1918-9. 2002
  89. ncbi Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation
    G Ciancio
    Department of Surgery, University of Miami School of Medicine, and the Miami Veterans Administration Medical Center, FL 33101, USA
    Transpl Int 13:S191-4. 2000
    ..This combination is safe and effective as an alternative immunosuppressive regimen after SPK transplantation...
  90. ncbi Can acute rejection be prevented in SPK transplantation?
    George W Burke
    Department of Surgery, Division of Transplantation, University of Miami School of Medicine, Highland Professional Building 5th Floor, 1801 NW 9th Avenue, Rm 521, Miami, FL 33136, USA
    Transplant Proc 34:1913-4. 2002
  91. ncbi Vascular complications following bladder drained, simultaneous pancreas-kidney transplantation: the University of Miami experience
    G Ciancio
    Department of Surgery, University of Miami School of Medicine, and the Miami Veterans Administration, Medical Center, Florida, USA
    Transpl Int 13:S187-90. 2000
    ..Surgery seems to be the best treatment option in the case of AVF or complete thrombosis of the allograft. Intravenous heparin followed by oral anticoagultion could be a conservative approach for SV thrombosis...
  92. ncbi Genitourinary tuberculosis after renal transplantation: report of 3 cases and review
    L Dowdy
    Division of Infectious Diseases, Department of Medicine, University of Miami School of Medicine, Miami, FL 33136, USA
    Clin Infect Dis 32:662-6. 2001
    ..Genitourinary tuberculosis is associated with graft rejection, and this diagnosis should be considered for renal transplant recipients with unexplained fever and constitutional symptoms...
  93. ncbi Ureteral reconstruction and bladder augmentation using intestinal allograft in a modified multivisceral transplant patient
    H Haider
    Department of Surgery, University of Miami, Florida, USA
    Am J Transplant 6:1968-71. 2006
    ..We herein report the use of a segment of transplanted ileum for this purpose in a patient with Gardner's syndrome who underwent multivisceral transplantation. To our knowledge this is the first such case report...
  94. ncbi Bezoar-related pancreatitis in enterically drained pancreas transplant
    H H Haider
    Lillian Jean Kaplan Renal Transplant Center of the Division of Transplantation of the Department of Surgery, at the University of Miami, Leonard M Miller School of Medicine, Miami, FL 33136, USA
    Transplant Proc 39:196-8. 2007
    ..To the best of our knowledge, this is the first case of allograft pancreatitis reported in the literature occurring from bezoar formation...
  95. ncbi Partial bladder transplantation with en bloc kidney transplant--the first case report of a 'bladder patch technique' in a human
    T Kato
    Division of Transplant, University of Miami, Miami, FL, USA
    Am J Transplant 8:1060-3. 2008
    ..No reflux across the donor UVJs was seen in a voiding cystourethrogram. The child is doing well with normal renal function at 18-month follow-up...
  96. ncbi Reactivation of dormant cutaneous Leishmania infection in a kidney transplant patient
    Marjan Mirzabeigi
    Department of Pathology, School of Medicine, University of Miami, Miami, FL, USA
    J Cutan Pathol 33:701-4. 2006
    ....
  97. ncbi The use of natural veno-venous bypass during surgical treatment of renal cell carcinoma with inferior vena cava thrombus
    Gaetano Ciancio
    Department of Surgery, University of Miami School of Medicine, Florida 33101, USA
    Am Surg 68:488-90. 2002
    ..These natural veno-venous bypasses allow vascular isolation of the inferior vena cava without disturbing the venous return to the heart and thereby help to prevent hemodynamic instability...
  98. ncbi Surgical techniques for treating a renal neoplasm invading the inferior vena cava
    Anil Vaidya
    Department of Urology, University of Miami School of Medicine, Miami, Florida, USA
    J Urol 169:435-44. 2003
    ..Hypothermic circulatory arrest should be considered when treating vena caval-atrial tumor thrombus. Surgeons familiar with liver mobilization can greatly facilitate the exposure needed for safely operating in these cases...
  99. ncbi Orthotopic ileal neobladder reconstruction after renal transplant
    T Cooke
    Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA
    Am J Transplant 7:2630-3. 2007
    ..There were no increased complications seen in these patients. Our cases demonstrate that an orthotopic ileal neobladder is safe and feasible after renal transplant and should be offered to these patients...
  100. ncbi Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity
    A Martin-Pagola
    Diabetes Research Institute, Leonard Miller School of Medicine, University of Miami, 1450 NW 10th Avenue, Miami, FL 33136, USA
    Diabetologia 51:1803-13. 2008
    ..We investigated whether beta cell neoformation occurs in the transplanted pancreas in patients with type 1 diabetes who had received a simultaneous pancreas-kidney transplant (SPK) and later developed recurrence of autoimmunity...
  101. ncbi Dual kidney transplantation using midline extraperitoneal approach: description of a technique
    H H Haider
    Lillian Jean Kaplan Renal Transplant Center, Division of Transplantation, Department of Surgery, Leonard M Miller School of Medicine, University of Miami, Miami, FL, USA
    Transplant Proc 39:1118-9. 2007
    ..In this report, we describe a simple technique of transplanting these organs extraperitoneally through a lower midline incision...